Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2011
12/15/2011US20110306610 9-substituted 8-oxoadenine compound
12/15/2011US20110306606 Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same
12/15/2011US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011US20110306599 Indole compounds and pharmaceutical use thereof
12/15/2011US20110306597 Nicotinamide Derivatives
12/15/2011US20110306595 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/15/2011US20110306593 Gamma secretase modulators
12/15/2011US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011US20110306591 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
12/15/2011US20110306590 Aryl- and heteroaryl- nitrogen-heterocyclic compounds as pde10 inhibitors
12/15/2011US20110306589 Nitrogen containing heteroaryl compounds
12/15/2011US20110306588 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
12/15/2011US20110306587 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
12/15/2011US20110306082 "benzoxazole-based fluorescent metal ion indicators"
12/15/2011US20110305661 Carbazole Compounds and Therapeutic Uses of the Compounds
12/15/2011US20110303850 Novel discriminating molecule family for neutron and gamma radiation
12/15/2011DE102009041242A1 New heterocyclically substituted aryl compounds are hypoxia-inducible factor inhibitors useful to treat and/or prevent e.g. cancer or tumor diseases, ischemic cardiovascular diseases, heart attack, arrhythmia, stroke, and psoriasis
12/15/2011CA2801939A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
12/15/2011CA2801909A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011CA2800203A1 Morpholino pyrimidines and their use in therapy
12/15/2011CA2800114A1 Process for the preparation of dihydropyrrole derivatives
12/15/2011CA2799640A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011CA2799022A1 Nitrogen containing heteroaryl compounds
12/14/2011EP2395573A1 Organic electroluminescent element, and illumination device and display device each comprising the element
12/14/2011EP2395003A1 Pyrazole compounds as sigma receptor inhibitors
12/14/2011EP2394999A1 Aminopyrazine derivative and medicine
12/14/2011EP2394995A1 Ring-fused 2-pyridone derivatives and herbicides
12/14/2011EP2393809A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/14/2011EP2393808A1 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
12/14/2011EP2393807A1 Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
12/14/2011EP2393806A1 Inhibitors of jun n-terminal kinase
12/14/2011EP2393804A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
12/14/2011EP2393802A1 Dihydroquinolinone derivatives
12/14/2011EP2393789A1 Isoxazole-3-carboxamide derivatives
12/14/2011EP2393777A1 Hydrazide compound and use of the same in pest control
12/14/2011EP2393360A1 Pyridazinone compounds
12/14/2011EP2393359A1 Linked dibenzimidazole derivatives
12/14/2011EP2178840B1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
12/14/2011EP2167499B1 Substituted oxazolidinones and use thereof
12/14/2011EP2021324B1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/14/2011EP1934206B1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
12/14/2011EP1917262B1 Piperidine and piperazine derivatives as p2x3 antagonists
12/14/2011CN1938273B 四氢咔唑类及衍生物 Tetrahydrocarbazole class and derivative
12/14/2011CN102282144A 作为神经鞘胺醇-1-磷酸酯1受体促效剂的*二唑衍生物 As a sphingosine-1-phosphate receptor agonist * oxadiazole derivatives
12/14/2011CN102282143A 具有杂环取代基的芳基化合物和它们的应用 Aryl compounds having heterocyclic substituents and their applications
12/14/2011CN102282142A 取代的芳族化合物和它们的用途 Substituted aromatic compounds and their use
12/14/2011CN102282139A 作为nk3受体拮抗剂的哌啶衍生物 As nk3 receptor antagonists piperidine derivative
12/14/2011CN102282138A 二酰基甘油酰基转移酶的抑制剂 Diacylglycerol acyltransferase inhibitors
12/14/2011CN102282132A 二酰基甘油酰基转移酶的抑制剂 Diacylglycerol acyltransferase inhibitors
12/14/2011CN102282130A 用于有机电致发光器件的材料 For organic electroluminescent device material
12/14/2011CN102281919A 二酰基甘油酰基转移酶的抑制剂 Diacylglycerol acyltransferase inhibitors
12/14/2011CN102276595A 含有五元杂环的噁唑烷酮抗菌素 Oxazolidinone antibiotic-containing five-membered heterocyclic ring
12/14/2011CN102276594A 一种新型伊潘立酮药物共晶及其制备方法 A new drug iloperidone eutectic and its preparation method
12/14/2011CN102276585A 4-取代-苯联芳基-羧酸酯类衍生物的制备方法及其医药用途 4-substituted - phenyl biaryl - carboxylic acid ester derivatives of preparation and pharmaceutical use
12/14/2011CN102276580A 吡唑甲酰基硫脲衍生物与制备方法和应用 Pyrazoloyl thiourea derivatives and preparation method and application
12/14/2011CN102276546A 用作蛋白聚糖酶调节剂的化合物及其应用 Compounds used as aggrecanase modulator and its application
12/14/2011CN101676271B 含有不饱和杂环胺的四环素衍生物 Unsaturated heterocyclic amines containing tetracycline derivatives
12/14/2011CN101374834B 用于调节fxr的化合物和方法 The compounds and methods for regulating fxr
12/14/2011CN101365685B 2-(苯并咪唑-1-基)-乙酰胺联芳基衍生物及它们作为trpv1受体抑制剂的用途 2- (benzimidazol-1-yl) - acetamide biaryl derivatives and their use as inhibitors of receptor trpv1
12/14/2011CN101218234B 作为代谢型谷氨酸受体的正变构调节剂的吡咯衍生物 As a metabotropic glutamate receptor positive allosteric modulators of pyrrole derivatives
12/13/2011US8076486 Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
12/13/2011US8076476 Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits
12/13/2011US8076369 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/13/2011US8076331 Substituted pyridazine derivatives
12/13/2011US8076330 Dipeptidyl peptidase-IV inhibitors
12/13/2011US8076329 Histamine H3-receptor ligands and their therapeutic applications
12/13/2011CA2634769C Nitrogen-containing bicyclic heteroaryl compounds and methods of use
12/13/2011CA2496139C Benzimidazole derivatives
12/13/2011CA2476008C Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
12/13/2011CA2449578C Pyrrolidine oxadiazole- and thiadiazole derivatives
12/08/2011WO2011153509A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
12/08/2011WO2011151808A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
12/08/2011WO2011151651A1 Benzodiazepine compounds useful for the treatment of hepatitis c
12/08/2011WO2011151163A1 Process for the preparation of oxadiazoles
12/08/2011WO2011123946A8 Kinase inhibitors and method of treating cancer with same
12/08/2011US20110301211 Antagonists of lysophosphatidic acid receptors
12/08/2011US20110301208 Viral and fungal inhibitors
12/08/2011US20110301205 Isoxazole derivatives for use as fungicides
12/08/2011US20110301204 Administration regime for nitrocatechols
12/08/2011US20110301203 Chemical compounds
12/08/2011US20110301175 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
12/08/2011US20110301163 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
12/08/2011US20110301162 Aurora kinase modulators and methods of use
12/08/2011US20110301161 Benzimidazole inhibitors of leukotriene production
12/08/2011US20110301159 Kinase inhibitor compounds
12/08/2011US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011US20110301150 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
12/08/2011US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011US20110301143 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/08/2011US20110301142 Antagonists of lysophosphatidic acid receptors
12/08/2011US20110301141 Aminopyrimidine derivatives as lrrk2 inhibitors
12/08/2011US20110301140 Pyridine Carboxamide orexin Receptor Antagonists
12/08/2011US20110301134 Alkyne antagonists of lysophosphatidic acid receptors
12/08/2011US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011US20110301122 Heteroaromatic compounds for use as hif inhibitors
12/08/2011US20110301112 Fused ring thrombin receptor antagonists
12/08/2011US20110301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof
12/08/2011US20110300165 Substituted isoxazole compounds
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 647